226 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (645)
- Autoimmune Disorders (1)
- Blood Disorders (4)
- Cancer
(553)
- Bladder Cancer (12)
- Brain Cancer (12)
- Breast Cancer (58)
- Gastrointestinal (10)
- Gynecologic Cancer (29)
- Head and Neck Cancer (4)
- Kidney Cancer (7)
- Leukemia (61)
- Liver Cancer (3)
- Lung Cancer (57)
- Lymphoma (23)
- Multiple Myeloma (24)
- Pancreatic Cancer (5)
- Prostate Cancer (25)
- Sarcoma (23)
- Skin Cancer (26)
- Solid Tumors (36)
- (-) Thyroid Cancer (1)
- Uveal Melanoma (7)
- COVID-19 (Coronavirus) (1)
- Diabetes (1)
- Ear, Nose and Throat (1)
- Endocrine & Metabolic Disease (1)
- Gastrointestinal and Digestive Diseases (2)
- Healthy Volunteers (6)
- Liver Disease (1)
- Neurological Disorders (22)
- Obstetrics & Gynecology (6)
- Pediatrics (40)
- Psychiatric Disorders (1)
- Surgery (1)
- Transplant (3)
- Urology (1)
Displaying 1 - 1 of 1
Condition: Cancer / Thyroid Cancer
Investigator: Antonio Fojo, MD, PhD
Status: Closed
This is a study designed for patients with medullary thyroid cancer. Treatment will consist of a drug called Ponatinib. Ponatinib is an investigational agent that blocks abnormal cancer proteins and therefore harms cancer cells. It was recently approved by the Food…